MENU
JANX
Stock ticker: NASDAQ
PRICE
CHANGE
CAPITALIZATION
Janux Therapeutics (JANX) Earnings Date & Reports
Janux Therapeutics Inc is a clinical-stage biopharmaceutical company developing tumor-activated immunotherapies for cancer... Show more
A.I. Advisor
published Earnings
JANX is expected to report earnings to rise 21.49% to -47 cents per share on November 10
Q3'26
Est.
$-0.47
Q1'26
Beat
by $0.18
Q4'25
Beat
by $0.11
Q3'25
Beat
by $0.23
Q2'25
Missed
by $0.09
The last earnings report on May 07 showed earnings per share of -38 cents, beating the estimate of -56 cents. With 288.72K shares outstanding, the current market capitalization sits at 1.18B.
View a ticker or compare two or three
VS
VS
Interact to see
Advertisement
Advertisement
A.I.Advisor
published price charts
A.I. Advisor
published General Information
General Information
Industry Biotechnology
Profile
Details
Industry
N/A
Address
10955 Vista Sorrento Parkway
Phone
+1 858 751-4493
Employees
109
Web
https://www.januxrx.com